Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar + mPFC in Esophageal Cancer
NCT02749526Phase 2Terminated
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Apr 2016
- Primary completion
- Dec 2018
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of endostar in esophageal cancer, sponsored by Jiangsu Provincial People's Hospital. Started Apr 2016; status: terminated.
02
Drugs
endostar
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT02749526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02749526.